73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Levonorgestrel IUD feasible for low-risk, early uterine cancer

Levonorgestrel IUD feasible for low-risk, early uterine cancer

(HealthDay)—A levonorgestrel-releasing intrauterine device (LNG-IUD) is effective in the majority of patients undergoing conservative treatment for low-risk endometrial cancer and complex atypical hyp

Levonorgestrel IUD feasible for low-risk, early uterine cancer

(HealthDay)—A levonorgestrel-releasing intrauterine device (LNG-IUD) is effective in the majority of patients undergoing conservative treatment for low-risk endometrial cancer and complex atypical hyp
Researchers review the role of integrins in human hepatocellular carcinoma

Researchers review the role of integrins in human hepatocellular carcinoma

by Cactus CommunicationsIn a recent review article, researchers summarize the roles integrins play in cancer cells and the current status of anti-integrin therapy for cancer. As a family of unique tra

Researchers review the role of integrins in human hepatocellular carcinoma

by Cactus CommunicationsIn a recent review article, researchers summarize the roles integrins play in cancer cells and the current status of anti-integrin therapy for cancer. As a family of unique tra
Fungal association with tumors may predict worse outcomes

Fungal association with tumors may predict worse outcomes

by Weill Cornell Medical CollegeColonies of Candida tropicalis. Credit: Jennifer Conrad and the Iliev labThe presence of some fungal species in tumors predicts—and may even help drive—worse cance

Fungal association with tumors may predict worse outcomes

by Weill Cornell Medical CollegeColonies of Candida tropicalis. Credit: Jennifer Conrad and the Iliev labThe presence of some fungal species in tumors predicts—and may even help drive—worse cance
New targets for CAR-T cell therapy against acute myeloid leukemia through AI-assisted analysis

New targets for CAR-T cell therapy against acute myeloid leukemia through AI-assisted analysis

byHelmholtz Association of German Research CentresmCSF1R CART do not cause toxicity in mice. Credit:Nature Biotechnology(2023). https://doi.org/10.1038/s41587-023-01684-0Unlike other

New targets for CAR-T cell therapy against acute myeloid leukemia through AI-assisted analysis

byHelmholtz Association of German Research CentresmCSF1R CART do not cause toxicity in mice. Credit:Nature Biotechnology(2023). https://doi.org/10.1038/s41587-023-01684-0Unlike other
Fighting cancer is more efficient at dawn, study finds

Fighting cancer is more efficient at dawn, study finds

byUniversity of GenevaCredit: Unsplash/CC0 Public DomainThe ability of tumors to take hold and grow depends, among other things, on the effectiveness of the immune system in fighting them. Cance

Fighting cancer is more efficient at dawn, study finds

byUniversity of GenevaCredit: Unsplash/CC0 Public DomainThe ability of tumors to take hold and grow depends, among other things, on the effectiveness of the immune system in fighting them. Cance
Novel selenium carrier protein regulates ferroptosis in tumors and the brain

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn
Study: Palliative care provided at point of oncology surgery does not improve patient outcomes

Study: Palliative care provided at point of oncology surgery does not improve patient outcomes

by Vanderbilt University Medical CenterCredit: Unsplash/CC0 Public DomainOne of the most important advances in palliative care in oncology over the past 15 years has been the recognition that pal

Study: Palliative care provided at point of oncology surgery does not improve patient outcomes

by Vanderbilt University Medical CenterCredit: Unsplash/CC0 Public DomainOne of the most important advances in palliative care in oncology over the past 15 years has been the recognition that pal
Variation in cancer-causing KRAS mutations greater than thought

Variation in cancer-causing KRAS mutations greater than thought

by University of Eastern FinlandA mutation at the amino acid glycine 12 (orange) of the KRAS protein (purple) has an effect on KRAS dynamics. Credit: Tatu PantsarThe effects of KRAS mutations und

Variation in cancer-causing KRAS mutations greater than thought

by University of Eastern FinlandA mutation at the amino acid glycine 12 (orange) of the KRAS protein (purple) has an effect on KRAS dynamics. Credit: Tatu PantsarThe effects of KRAS mutations und
Football training may preserve bone health in prostate cancer patients

Football training may preserve bone health in prostate cancer patients

by WileyAndrogen deprivation therapy for the treatment of prostate cancer can lead to loss of muscle and bone mass. In a recent Scandinavian Journal of Medicine & Science in Sport study of el

Football training may preserve bone health in prostate cancer patients

by WileyAndrogen deprivation therapy for the treatment of prostate cancer can lead to loss of muscle and bone mass. In a recent Scandinavian Journal of Medicine & Science in Sport study of el
Researchers identify drug resistance factors for advanced prostate cancer

Researchers identify drug resistance factors for advanced prostate cancer

by Mayo ClinicThe DNA/RNA processing used both single sample and multi-sample analyses as part of the processing. Credit:Molecular Cancer Research(2022). DOI: 10.1158/1541-7786.MCR-22

Researchers identify drug resistance factors for advanced prostate cancer

by Mayo ClinicThe DNA/RNA processing used both single sample and multi-sample analyses as part of the processing. Credit:Molecular Cancer Research(2022). DOI: 10.1158/1541-7786.MCR-22
Small molecule inhibitors show early-stage promise against YAP fusion-driven cancers

Small molecule inhibitors show early-stage promise against YAP fusion-driven cancers

byCincinnati Children's Hospital Medical CenterIn an early proof-of-concept success, a team led by experts at Cincinnati Children's reports that mice induced to develop brain tumors feat

Small molecule inhibitors show early-stage promise against YAP fusion-driven cancers

byCincinnati Children's Hospital Medical CenterIn an early proof-of-concept success, a team led by experts at Cincinnati Children's reports that mice induced to develop brain tumors feat
Dosing regimen for an old cancer drug shows new promise as an immunotherapy

Dosing regimen for an old cancer drug shows new promise as an immunotherapy

by Bendta Schroeder,Massachusetts Institute of TechnologyA cancer cell (blue, center) can elude attack by immune cells (such as these T cells shown in green and red) by sequestering the mutated

Dosing regimen for an old cancer drug shows new promise as an immunotherapy

by Bendta Schroeder,Massachusetts Institute of TechnologyA cancer cell (blue, center) can elude attack by immune cells (such as these T cells shown in green and red) by sequestering the mutated